Healthcare provider profile · identity verified

Thomas O Bailey, MD

Family Practice · MARIANNA, AR · NPI 1851403422

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	601	83
Amlodipine Besylate	Amlodipine Besylate	515	130
Atorvastatin Calcium	Atorvastatin Calcium	268	73
Omeprazole	Omeprazole	248	66
Gabapentin	Gabapentin	239	58
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	204	48
Furosemide	Furosemide	184	58
Promethazine Hcl	Promethazine Hcl	158	24
Metoprolol Tartrate	Metoprolol Tartrate	151	47
Simvastatin	Simvastatin	147	42
Losartan Potassium	Losartan Potassium	145	39
Metformin Hcl	Metformin Hcl	137	42
Nifedipine Er	Nifedipine	129	27
Azithromycin	Azithromycin	127	88
Lisinopril	Lisinopril	118	29
Albuterol Sulfate Hfa	Albuterol Sulfate	112	35
Potassium Chloride	Potassium Chloride	106	21
Levothyroxine Sodium	Levothyroxine Sodium	101	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	100	20
Tamsulosin Hcl	Tamsulosin Hcl	97	29
Zolpidem Tartrate	Zolpidem Tartrate	97	16
Ibuprofen	Ibuprofen	91	24
Hydrochlorothiazide	Hydrochlorothiazide	87	27
Famotidine	Famotidine	86	23
Carvedilol	Carvedilol	79	21
Pioglitazone Hcl	Pioglitazone Hcl	79	21
Tramadol Hcl	Tramadol Hcl	78	34
Diazepam	Diazepam	77	13
Pantoprazole Sodium	Pantoprazole Sodium	71	22
Meloxicam	Meloxicam	67	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	27
Eliquis	Apixaban	62	suppressed
Penicillin V Potassium	Penicillin V Potassium	62	15
Metoprolol Succinate	Metoprolol Succinate	61	12
Glipizide	Glipizide	57	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	16
Clopidogrel	Clopidogrel Bisulfate	53	21
Allopurinol	Allopurinol	52	17
Diclofenac Sodium	Diclofenac Sodium	49	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	49	30
Triamcinolone Acetonide	Triamcinolone Acetonide	49	14
Lorazepam	Lorazepam	44	16
Hydrocortisone	Hydrocortisone	43	24
Tizanidine Hcl	Tizanidine Hcl	42	suppressed
Naproxen	Naproxen	40	11
Linzess	Linaclotide	39	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	37	suppressed
Ertapenem	Ertapenem Sodium	36	suppressed
Montelukast Sodium	Montelukast Sodium	35	suppressed
Mupirocin	Mupirocin	34	23
Cephalexin	Cephalexin	32	22
Glipizide Er	Glipizide	31	11
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Atenolol	Atenolol	25	suppressed
Levofloxacin	Levofloxacin	25	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	25	11
Alprazolam	Alprazolam	24	suppressed
Sertraline Hcl	Sertraline Hcl	24	13
Spironolactone	Spironolactone	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Indomethacin	Indomethacin	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	22	suppressed
Colchicine	Colchicine	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	21	suppressed
Brilinta	Ticagrelor	20	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Divalproex Sodium	Divalproex Sodium	20	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Trazodone Hcl	Trazodone Hcl	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	11
Memantine Hcl	Memantine Hcl	18	suppressed
Risperidone	Risperidone	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Finasteride	Finasteride	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Methylprednisolone	Methylprednisolone	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Humulin R	Insulin Regular, Human	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Digoxin	Digoxin	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Warfarin Sodium	Warfarin Sodium	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Cyproheptadine Hcl	Cyproheptadine Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Jardiance	Empagliflozin	12	suppressed
Lactulose	Lactulose	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Metolazone	Metolazone	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	12	suppressed
Valsartan	Valsartan	12	suppressed
Velphoro	Sucroferric Oxyhydroxide	12	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Ozempic	Semaglutide	11	suppressed
Trueplus Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error